Jeffrey Autrey has worked with Pfizer since 2004 as first a US hub and later as a global submission manager, making him responsible for the coordination and delivery of regulatory submissions to all major eCTD regions around the globe. At the company, Jeffrey Autrey works with endgame committees and submission teams to develop long-term project strategies.

Within these teams, he also advocates for realistic deliverable timelines and ensures compliance with all regional technical validation criteria. On major submission projects, he partners with various work streams including clinicians, medical writers, early development scientists, CMC specialists, and regulatory strategists to manage document standards and development timelines.

Since joining the company, Mr. Autrey has twice earned Pfizer’s Saxton Clinical Development Large Team Award. He received this recognition in 2019 and 2020 for his work on Bavencio’s drug submissions in the United States.

Earlier in his regulatory career as a US submissions manager, Jeffrey Autrey oversaw clinical compliance and archival records tracking. He also managed review cycles for nonclinical and clinical studies. He holds a master’s degree in quality assurance and regulatory affairs from Temple University.